Vaidya Sane Ayurved Laboratories Limited

NSE: MADHAVBAUG · Unclassified

₹135.95-12.49%06 Nov 2026

Ask the data

Instant answers about Vaidya Sane Ayurved Laboratories Limited — computed from its filings, no language model

Market cap₹143 cr

Current price₹135.95

High / Low₹294 / ₹134

P/E15.9

P/B2.00

Book value₹68.1

ROE12.5%

ROCE15.7%

Debt / equity0.04

Dividend yield—

EPS (TTM)₹8.54

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY23	FY24	FY25	FY26
Revenue	53.6	99.3	89.8	106.9
EBITDA	3.7	4.5	13.5	15.4
Operating margin	6.9%	4.5%	15.0%	14.4%
Interest	0.1	0.2	0.1	0.8
Depreciation	1.4	3.1	4.2	6.1
Profit before tax	2.7	2.9	9.9	10.8
Tax	0.6	0.9	2.7	1.8
Net profit	2.1	-0.0	7.2	9.0
EPS ₹	1.99	1.88	6.76	8.51
Operating cash flow	0.1	-4.4	10.6	5.4
Capex	7.0	11.1	8.4	7.9
Dividend paid	0.3	0.3	0.0	0.0
Total assets	—	—	76.7	104.5
Equity	—	—	62.5	71.7

Half-yearly performance

last 8 half years · ₹ crore

showing latest 6 of 8 periods

	H1 FY23*	H2 FY23	H1 FY24	H2 FY24	H1 FY25	H2 FY25	H1 FY26	H2 FY26
Revenue	-45.6	99.2	51.1	48.2	41.8	48.0	49.9	57.0
Operating profit	-4.2	7.9	2.7	1.8	5.8	7.7	8.6	6.8
Operating margin	9.1%	7.9%	5.2%	3.8%	13.8%	16.1%	17.3%	11.9%
Other income	-0.8	1.4	0.6	1.1	0.8	1.0	0.9	1.4
Interest	-0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.8
Depreciation	-1.2	2.6	1.6	1.6	1.9	2.4	3.0	3.1
Profit before tax	-3.7	6.4	1.6	1.3	4.6	5.2	6.5	4.3
Tax	-1.0	1.6	0.4	0.5	1.3	1.8	1.6	0.2
Net profit	-2.7	4.8	1.2	0.8	3.2	3.4	4.8	4.2
EPS ₹	-2.61	4.60	1.12	0.76	3.59	3.17	4.56	3.95
Revenue YoY	—	—	—	-51.4%	-18.2%	-0.4%	19.5%	18.5%
Profit YoY	—	—	—	-83.4%	175.4%	326.2%	48.6%	22.0%

Returns & margins

trailing-twelve-month, per half year

showing latest 6 of 7 periods

	H2 FY23	H1 FY24	H2 FY24	H1 FY25	H2 FY25	H1 FY26	H2 FY26
ROE	—	—	—	6.9%	10.6%	12.2%	12.5%
ROCE	—	—	—	10.1%	15.4%	17.2%	15.7%
Net margin	3.9%	4.0%	2.0%	4.5%	7.4%	8.4%	8.4%
EBITDA margin	6.9%	7.0%	4.5%	8.4%	15.0%	16.7%	14.4%
Debt / equity	—	—	—	0.02	0.02	0.01	0.04
Interest coverage	39.57	23.86	12.48	35.65	89.55	90.38	13.72
Asset turnover	—	—	—	1.25	1.17	1.19	1.02

Balance sheet

equity vs borrowings over time · ₹ crore

	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	10.5	10.5	10.5	10.5
Other equity / reserves	34.9	52.0	57.2	61.2
Total equity	58.9	62.5	67.7	71.7
Borrowings	1.1	1.5	0.6	2.6
Current liabilities	11.4	11.2	11.1	11.1
Non-current liabilities	1.9	3.0	3.2	6.0
Total assets	72.1	76.7	82.0	104.5
Property, plant & equipment	15.6	21.4	20.9	21.9
Investments	1.0	21.3	21.7	39.9
Inventories	3.5	3.8	3.4	3.6
Receivables	5.0	7.5	7.8	10.2
Cash & equivalents	19.4	2.4	5.5	0.4

Cash flow

annual · ₹ crore · line = free cash flow

	FY23	FY24	FY25	FY26
Cash from operations	0.1	-4.4	10.6	5.4
Cash from investing	0.5	1.5	-10.1	-24.0
Cash from financing	-1.4	14.5	-0.5	16.7
Capex	7.0	11.1	8.4	7.9
Free cash flow	-6.9	-15.6	2.2	-2.5
Dividends paid	0.3	0.3	0.0	0.0

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹21.9 cr21%

Investments

₹39.9 cr38%

Inventories

₹3.6 cr3%

Receivables

₹10.2 cr10%

Cash & equivalents

₹0.4 cr0%

Other assets

₹28.4 cr27%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Vaidya Sane Ayurved Laboratories Limited	143	135.95	15.9	2.00	12.5%

StoxGud checklist: Bearish setup · 3/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-21.2%

6 months-29.4%

1 year-52.9%

3Y CAGR-23.2%

5Y CAGR—

10Y CAGR—

50-day avg₹161.68

200-day avg₹202.70

RSI (14)28

FAQs

What is the share price of Vaidya Sane Ayurved Laboratories Limited?

Vaidya Sane Ayurved Laboratories Limited (MADHAVBAUG) closed at ₹135.95 on NSE on 06 Nov 2026.

What is the market cap of Vaidya Sane Ayurved Laboratories Limited?

₹143 crore at the latest close.

What is the P/E ratio of Vaidya Sane Ayurved Laboratories Limited?

15.9, on trailing-twelve-month earnings from its filings.

How fast is Vaidya Sane Ayurved Laboratories Limited growing?

Vaidya Sane Ayurved Laboratories Limited: revenue has compounded at 25.9% a year over three years; net profit at 62.4% a year. Latest-half-year revenue is up 18.5% year on year, profit up 22.0%.

How profitable is Vaidya Sane Ayurved Laboratories Limited?

On a trailing-twelve-month basis return on equity is 12.5%, return on capital employed 15.7%, operating margin 14.4%, net margin 8.4%.

How much debt does Vaidya Sane Ayurved Laboratories Limited have?

Vaidya Sane Ayurved Laboratories Limited is debt-free: debt to equity is 0.04 with borrowings of ₹3 cr against cash of ₹0 cr (balance sheet of 2026-03-31). Operating profit covers interest 13.7 times.

Financials parsed from Vaidya Sane Ayurved Laboratories Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Half-yearly from H1 FY23, annual from FY23, balance sheet from Sep '24. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.